These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack. Martinez-Arroyo O; Gruevska A; Victor VM; González-Polo RA; Yakhine-Diop SMS; Fuentes JM; Esplugues JV; Blas-Garcia A; Apostolova N Antiviral Res; 2019 Aug; 168():36-50. PubMed ID: 31075350 [TBL] [Abstract][Full Text] [Related]
4. Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China. Gao L; Xia H; Zeng R; Wu Y; Zaongo SD; Hu Y; Ma P HIV Med; 2022 Mar; 23 Suppl 1():84-94. PubMed ID: 35293099 [TBL] [Abstract][Full Text] [Related]
5. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System. Moure R; Domingo P; Villarroya J; Gasa L; Gallego-Escuredo JM; Quesada-López T; Morón-Ros S; Maroto AF; Mateo GM; Domingo JC; Villarroya F; Giralt M Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29661866 [TBL] [Abstract][Full Text] [Related]
7. HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders. Cheney L; Guzik H; Macaluso FP; Macian F; Cuervo AM; Berman JW Cells; 2020 Jun; 9(6):. PubMed ID: 32526847 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy in HIV. Yu A; Berbari E; Temesgen Z J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997 [TBL] [Abstract][Full Text] [Related]
9. Sarcopenia in Persons Living with HIV under Antiretroviral Therapy: Literature Review. Dos-Santos-Quaresma MVL; Lima-Ribeiro SM AIDS Rev; 2022 Mar; 24(1):1-15. PubMed ID: 34082442 [TBL] [Abstract][Full Text] [Related]
10. HIV Increases the Inhibitory Impact of Morphine and Antiretrovirals on Autophagy in Primary Human Macrophages: Contributions to Neuropathogenesis. Barbaro JM; Cuervo AM; Berman JW Cells; 2021 Aug; 10(9):. PubMed ID: 34571832 [TBL] [Abstract][Full Text] [Related]
12. Abacavir: a review of its clinical potential in patients with HIV infection. Hervey PS; Perry CM Drugs; 2000 Aug; 60(2):447-79. PubMed ID: 10983741 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities. Ross L; Lim ML; Liao Q; Wine B; Rodriguez AE; Weinberg W; Shaefer M HIV Clin Trials; 2007; 8(1):1-8. PubMed ID: 17434843 [TBL] [Abstract][Full Text] [Related]
14. Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort. Stoll M; Kollan C; Bergmann F; Bogner J; Faetkenheuer G; Fritzsche C; Hoeper K; Horst HA; van Lunzen J; Plettenberg A; Reuter S; Rockstroh J; Stellbrink HJ; Hamouda O; Bartmeyer B; PLoS One; 2011; 6(9):e23946. PubMed ID: 21931626 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular toxicity of contemporary antiretroviral therapy. Vos AG; Venter WDF Curr Opin HIV AIDS; 2021 Nov; 16(6):286-291. PubMed ID: 34545036 [TBL] [Abstract][Full Text] [Related]
16. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV. Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426 [TBL] [Abstract][Full Text] [Related]
18. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Cvetkovic RS; Goa KL Drugs; 2003; 63(8):769-802. PubMed ID: 12662125 [TBL] [Abstract][Full Text] [Related]
19. Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings. Hosseinipour MC; Gupta RK; Van Zyl G; Eron JJ; Nachega JB J Infect Dis; 2013 Jun; 207 Suppl 2(Suppl 2):S49-56. PubMed ID: 23687289 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms? Maagaard A; Kvale D J Antimicrob Chemother; 2009 Nov; 64(5):901-9. PubMed ID: 19740910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]